Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: clinical activity and biological correlations
Titel:
Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: clinical activity and biological correlations
Auteur:
Cristofanilli, M. Morandi, P. Krishnamurthy, S. Reuben, J.M. Lee, B.-N. Francis, D. Booser, D.J. Green, M.C. Arun, B.K. Pusztai, L. Lopez, A. Islam, R. Valero, V. Hortobagyi, G.N.